Predictors of hospital readmission two years after coronary artery bypass grafting.
暂无分享,去创建一个
J Herlitz | J. Herlitz | G. Brandrup-Wognsen | P. Albertsson | B. Karlson | T. Karlsson | M. Hartford | M. Haglid | H. Emanuelsson | T. Karlsson | B W Karlson | A Hjalmarson | Å. Hjalmarson | H Emanuelsson | G Brandrup-Wognsen | M Haglid | T Karlsson | P Albertsson | W. Sandén | M Hartford | W Sandén | G. Brandrup‐Wognsen | Per Albertsson | Håkan Emanuelsson
[1] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[2] K. Hammermeister,et al. Effect of coronary artery bypass grafting on subsequent hospitalization. , 1983, The American journal of cardiology.
[3] Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group. , 1995, European heart journal.
[4] T. David,et al. Current risk of coronary bypass for unstable angina. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[5] F. Loop,et al. Rehospitalizations after coronary revascularization among Medicare beneficiaries. , 1993, The American journal of cardiology.
[6] C. Jenkins,et al. Hospital readmissions among survivors six months after myocardial revascularization. , 1985, JAMA.
[7] F. Grover,et al. Initial report of the Veterans Administration Preoperative Risk Assessment Study for Cardiac Surgery. , 1990, The Annals of thoracic surgery.
[8] J. Herlitz,et al. Ten-year mortality rate after development of acute myocardial infarction in relation to clinical history and observations during hospital stay: experience from the Göteborg metoprolol trial. , 1993, Coronary artery disease.
[9] J. Manson,et al. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. , 1991, Annals of internal medicine.
[10] J. Herlitz,et al. Mortality during the two years after coronary artery bypass grafting in relation to perioperative factors and urgency of operation. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[11] F. Harrell,et al. The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. , 1989, JAMA.
[12] L. Smith,et al. Preoperative determinants of postoperative costs associated with coronary artery bypass graft surgery. , 1994, Circulation.
[13] P. Vuorinen. Obesity and the Heart , 1963, British medical journal.
[14] K. Swedberg,et al. EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION A Double-blind Randomised Trial , 1981, The Lancet.
[15] L. Bolognese,et al. RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.
[16] A. Maggioni,et al. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. , 1993, Journal of the American College of Cardiology.